Literature DB >> 15337974

Local neural block at the wrist for treatment of palmar hyperhidrosis with botulinum toxin: technical improvements.

Anna Campanati1, G Lagalla, L Penna, R Gesuita, A Offidani.   

Abstract

BACKGROUND: Wrist blockage of median and ulnar nerves before treatment of palmar hyperhidrosis with botulinum toxin (BTX-A) reduces discomfort and improves accuracy of BTX-A injections, but can be associated with mechanical/chemical injury.
OBJECTIVES: We sought to compare locoregional anesthesia of median and ulnar nerves using conventional 25-G x 0.50 x 13 mm gauge needle with short 30-G x 0.40 x 6 mm gauge needle.
METHODS: In all, 37 patients with idiopathic, recalcitrant palmar hyperhidrosis were treated with BTX-A after median and ulnar nerve blockage. In 18 patients, a conventional needle was used to achieve nerve blockage and in 19 the short needle was used. The 2 groups of patients were compared for analgesic effects and lag phase.
RESULTS: No differences were found between groups for lag phase (P=.26) and discomfort of subsequent BTX-A treatment (P=1.0).
CONCLUSION: The use of a short-gauge needle to block median and ulnar nerves is a suitable method to anesthetize the palm before treatment with BTX-A.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15337974     DOI: 10.1016/j.jaad.2003.09.006

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

Review 1.  Botulinum Toxin Off-Label Use in Dermatology: A Review.

Authors:  Anna Campanati; Emanuela Martina; Katia Giuliodori; Veronica Consales; Ivan Bobyr; Annamaria Offidani
Journal:  Skin Appendage Disord       Date:  2017-02-01

2.  Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system.

Authors:  Dirk Dressler
Journal:  J Neurol       Date:  2012-08-10       Impact factor: 4.849

3.  Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial.

Authors:  A Campanati; K Giuliodori; E Martina; A Giuliano; G Ganzetti; A Offidani
Journal:  J Neural Transm (Vienna)       Date:  2013-09-20       Impact factor: 3.575

4.  Botulinum toxin therapy for hyperhidrosis: reduction of injection site pain by nitrous oxide/oxygen mixtures.

Authors:  Lejla Paracka; Katja Kollewe; Reinhard Dengler; Dirk Dressler
Journal:  J Neural Transm (Vienna)       Date:  2015-02-04       Impact factor: 3.575

5.  Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review.

Authors:  Emanuela Martina; Federico Diotallevi; Giulia Radi; Anna Campanati; Annamaria Offidani
Journal:  Toxins (Basel)       Date:  2021-02-05       Impact factor: 4.546

6.  Neurologic uses of botulinum neurotoxin type A.

Authors:  John P Ney; Kevin R Joseph
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.